LA JOLLA, Calif., Nov. 20, 2014 — SGI-DNA announces the launch of the Gibson Assembly® HiFi 1 Step Kit which allows researchers to assemble multiple, large DNA fragments in a simple one hour, one-step reaction. This is the first high fidelity kit on the market using the Gibson Assembly® method. Researchers can now assemble up […]
http://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.png00Emmyhttp://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.pngEmmy2014-11-20 17:19:472016-12-21 17:21:32SGI-DNA Launches Gibson Assembly® HiFi 1 Step Kit for Simple, Seamless and Rapid Construction of Synthetic Genes, Gene Clusters and Genetic Pathways
J. Craig Venter, Ph.D., Co-founder and Former CEO, becomes Executive Chairman and Co-Chief Scientist (LA JOLLA, CA) October 27, 2014- Synthetic Genomics, Inc. (SGI), a synthetic biology company commercializing genomic technologies to revolutionize several industries, today announced the appointment of Oliver Fetzer, Ph.D., MBA as the company’s new Chief Executive Officer (CEO). In his role […]
http://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.png00Emmyhttp://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.pngEmmy2014-10-27 09:32:272016-12-22 09:34:54Synthetic Genomics Inc. Appoints Oliver Fetzer, Ph.D., MBA as Chief Executive Officer
KEARNY, NJ and LA JOLLA, CA, JUNE 20, 2014 – Avoca, Inc., a division of Pharmachem Laboratories, Inc., has formed a supply agreement with Synthetic Genomics, Inc. (SGI), a privately held company developing and commercializing genomic driven solutions and products in a variety of industries, to extract and commercialize natural astaxanthin from a strain of […]
http://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.png00Emmyhttp://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.pngEmmy2014-06-20 09:35:142016-12-22 09:38:11Avoca Signs Supply Agreement with Synthetic Genomics Inc to Become Domestic Source of Natural Astaxanthin
LA JOLLA, Calif. and DECATUR, Ill, May 19, 2014 – Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Archer Daniels Midland Company (NYSE: ADM) announced today that the two companies have entered into a long-term agreement to commercialize Omega-3 Docosahexaenoic Acid (DHA) from […]
http://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.png00Emmyhttp://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.pngEmmy2014-05-19 09:38:212016-12-22 09:40:51Synthetic Genomics Inc. and ADM Announce Omega-3 DHA Strategic Partnership
Lung Biotechnology Also Makes $50M Equity Investment in SGI LA JOLLA, CA and SILVER SPRING, MD (May 6, 2014) – Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Lung Biotechnology Inc., a subsidiary of United Therapeutics Corporation (NASDAQ: UTHR), today announced they have […]
http://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.png00Emmyhttp://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.pngEmmy2014-05-06 09:41:112016-12-22 09:42:31Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize Transplantation Field
J. Craig Venter, Ph.D., Founder and CEO, Synthetic Genomics Inc. and Founder and CEO, the J. Craig Venter Institute “Today the United States Supreme Court ruled on the validity of BRAC1 and BRAC2 human gene patents stating that, ‘A naturally occurring DNA segment is a product of nature and not patent eligible merely because it […]
http://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.png00Emmyhttp://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.pngEmmy2013-06-13 09:42:552016-12-22 09:45:28Prepared Statement on the Supreme Court Human Gene Patent Ruling
Initial applications to focus on ethanol and hydrogen production ROCKVILLE, MD – June 29, 2005 – Synthetic Genomics, Inc., a new company that will develop and commercialize synthetic biology, was launched today. The Company will engineer modular “cassette” based systems to execute specific functions using reprogrammed cells as bio-factories. Synthetic Genomics, Inc.’s initial focus will be […]
http://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.png00Emmyhttp://syntheticgenomics.com/wp-content/uploads/SGI_LOGO.pngEmmy2005-06-29 10:26:312017-01-05 10:39:18Synthetic Genomics, Inc. Launched to Develop New Approaches to Biological Energy
SGI-DNA Launches Gibson Assembly® HiFi 1 Step Kit for Simple, Seamless and Rapid Construction of Synthetic Genes, Gene Clusters and Genetic Pathways
/in News /by EmmyLA JOLLA, Calif., Nov. 20, 2014 — SGI-DNA announces the launch of the Gibson Assembly® HiFi 1 Step Kit which allows researchers to assemble multiple, large DNA fragments in a simple one hour, one-step reaction. This is the first high fidelity kit on the market using the Gibson Assembly® method. Researchers can now assemble up […]
Synthetic Genomics Inc. Appoints Oliver Fetzer, Ph.D., MBA as Chief Executive Officer
/in News /by EmmyJ. Craig Venter, Ph.D., Co-founder and Former CEO, becomes Executive Chairman and Co-Chief Scientist (LA JOLLA, CA) October 27, 2014- Synthetic Genomics, Inc. (SGI), a synthetic biology company commercializing genomic technologies to revolutionize several industries, today announced the appointment of Oliver Fetzer, Ph.D., MBA as the company’s new Chief Executive Officer (CEO). In his role […]
Avoca Signs Supply Agreement with Synthetic Genomics Inc to Become Domestic Source of Natural Astaxanthin
/in News /by EmmyKEARNY, NJ and LA JOLLA, CA, JUNE 20, 2014 – Avoca, Inc., a division of Pharmachem Laboratories, Inc., has formed a supply agreement with Synthetic Genomics, Inc. (SGI), a privately held company developing and commercializing genomic driven solutions and products in a variety of industries, to extract and commercialize natural astaxanthin from a strain of […]
Synthetic Genomics Inc. and ADM Announce Omega-3 DHA Strategic Partnership
/in News /by EmmyLA JOLLA, Calif. and DECATUR, Ill, May 19, 2014 – Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Archer Daniels Midland Company (NYSE: ADM) announced today that the two companies have entered into a long-term agreement to commercialize Omega-3 Docosahexaenoic Acid (DHA) from […]
Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize Transplantation Field
/in News /by EmmyLung Biotechnology Also Makes $50M Equity Investment in SGI LA JOLLA, CA and SILVER SPRING, MD (May 6, 2014) – Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Lung Biotechnology Inc., a subsidiary of United Therapeutics Corporation (NASDAQ: UTHR), today announced they have […]
Prepared Statement on the Supreme Court Human Gene Patent Ruling
/in News /by EmmyJ. Craig Venter, Ph.D., Founder and CEO, Synthetic Genomics Inc. and Founder and CEO, the J. Craig Venter Institute “Today the United States Supreme Court ruled on the validity of BRAC1 and BRAC2 human gene patents stating that, ‘A naturally occurring DNA segment is a product of nature and not patent eligible merely because it […]
Synthetic Genomics, Inc. Launched to Develop New Approaches to Biological Energy
/in News /by EmmyInitial applications to focus on ethanol and hydrogen production ROCKVILLE, MD – June 29, 2005 – Synthetic Genomics, Inc., a new company that will develop and commercialize synthetic biology, was launched today. The Company will engineer modular “cassette” based systems to execute specific functions using reprogrammed cells as bio-factories. Synthetic Genomics, Inc.’s initial focus will be […]